Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulants in pregnancy.

P W Howie

    Clinics in Obstetrics and Gynaecology
    |June 1, 1986
    PubMed
    Summary

    Anticoagulants manage thromboembolic disorders in pregnancy, balancing risks like bleeding and embryopathy. Heparin and warfarin are options, each with unique maternal and fetal considerations for treatment and prevention.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Breast milk and the risk of opportunistic infection in infancy in industrialized and non-industrialized settings.

    Advances in nutritional research·2002
    Same author

    Rattling the plate--reasons and rationales for early weaning.

    Health education research·2001
    Same author

    Interval between fetal measurements in predicting growth restriction.

    Obstetrics and gynecology·2001
    Same author

    Using unconditional and conditional standard deviation scores of fetal abdominal area measurements in the prediction of intrauterine growth restriction.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2001
    Same author

    Task-based learning: the answer to integration and problem-based learning in the clinical years.

    Medical education·2000
    Same author

    UK study of intrapartum care for low risk primigravidas: a survey of interventions.

    Journal of epidemiology and community health·1999

    Area of Science:

    • Obstetrics and Gynecology
    • Hematology
    • Pharmacology

    Background:

    • Thromboembolic disorders pose significant risks during pregnancy, necessitating effective anticoagulation strategies.
    • Anticoagulant medications are crucial for both treating and preventing thromboembolic events in pregnant individuals.

    Purpose of the Study:

    • To review the roles, benefits, and risks of anticoagulants, including warfarin and heparin, in managing thromboembolic disorders during pregnancy.
    • To discuss current trends in anticoagulant prophylaxis and treatment, emphasizing individualized risk-benefit assessments.

    Main Methods:

    • Review of existing literature on anticoagulant use in pregnancy.
    • Analysis of warfarin and heparin efficacy, safety profiles, and administration routes (oral, intravenous, subcutaneous).
    • Examination of management strategies for acute thromboembolism and prophylaxis.

    Main Results:

    • Warfarin offers convenience but carries risks of maternal/fetal bleeding and potential embryopathy, though risks may be overstated.
    • Heparin, administered parenterally, avoids placental transfer but can cause bleeding; subcutaneous heparin is suitable for long-term use but may cause bruising and bone demineralization.
    • Standard acute treatment involves intravenous heparin followed by subcutaneous heparin or warfarin, with warfarin switched before delivery. Prophylaxis is becoming more selective.

    Conclusions:

    • No anticoagulant regimen is risk-free; management requires careful consideration of individual patient risk-benefit ratios.
    • Anticoagulation is essential for high-risk pregnancies, including those with artificial heart valves, often requiring a combination of warfarin and heparin.
    • Continuous reassessment of anticoagulation strategies is vital throughout pregnancy, labor, and the puerperium.

    Related Experiment Videos